Results 21 to 30 of about 757,777 (265)

Gynecologic cancers and solid organ transplantation [PDF]

American Journal of Transplantation, 2019
Solid organ transplant (SOT) recipients have an approximately 2-fold greater risk of developing and dying from a malignancy compared to the general population. Among the gynecologic cancers, including uterine, cervical, vaginal, vulvar, and ovarian, the HPV-related cancers are known to increase among women posttransplant compared to women in the ...
John B, Liao, Cynthia E, Fisher, Margaret M, Madeleine   +2 more
openaire   +2 more sources

Mathematical models of the solid cancer induced by atomic bomb and the spontaneous cancer in the daily life—Proposal of a new medical treatment for cancers

Cancer Reports, 2023
Background A mathematical model of the radiation−induced cancer was devised to explain the change of incidence rates pursued by Radiation Effect Research Foundation for 25 years. Aim The aim of this work is construction of mechanisms of radiation‐induced
Hiroshi Baba, Akihiko Yokoyama
doaj   +1 more source

Current Status of Next-Generation Sequencing-Based Cancer Genome Profiling Tests in Japan and Prospects for Liquid Biopsy

Life, 2021
Next-generation sequencing-based comprehensive genome profiling (CGP) testing, OncoGuide NCC Oncopanel System, and FoundationOne CDx Cancer Genomic Profile have been covered by the Japanese national health insurance system since June 2019.
Yumi Yoshii, Shunsuke Okazaki, Masayuki Takeda   +2 more
doaj   +1 more source

Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study

Frontiers in Immunology, 2022
ObjectiveTo explore the effectiveness of cryoablation combined with arterial perfusion with programmed cell death protein 1 inhibitors in overcoming immune resistance in advanced solid cancers.MethodsIn this pilot retrospective study, nine patients with ...
Fuqun Wei, Rui Guo, Yuan Yan, Ruixiang Lin, Jin Chen, Zhengyu Lin, Zhengyu Lin   +6 more
doaj   +1 more source

Genetic Predisposition to Solid Pediatric Cancers [PDF]

Frontiers in Oncology, 2020
Progresses over the past years have extensively improved our capacity to use genome-scale analyses-including high-density genotyping and exome and genome sequencing-to identify the genetic basis of pediatric tumors. In particular, exome sequencing has contributed to the evidence that about 10% of children and adolescents with tumors have germline ...
Mario Capasso, Mario Capasso, Annalaura Montella, Matilde Tirelli, Matilde Tirelli, Teresa Maiorino, Teresa Maiorino, Sueva Cantalupo, Sueva Cantalupo, Achille Iolascon, Achille Iolascon   +10 more
openaire   +4 more sources

A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers

Vaccines, 2023
Background: The recommended booster third dose of vaccination against COVID-19 in cancer patients seems reasonable to protect them against a severe disease course.
Urska Janzic, Urska Bidovec-Stojkovic, Peter Korosec, Katja Mohorcic, Loredana Mrak, Marina Caks, Maja Ravnik, Erik Skof, Matija Rijavec   +8 more
doaj   +1 more source

Radioimmunotherapy of Solid Cancers: A review [PDF]

Acta Oncologica, 1996
Depending on radionuclide characteristics, radioimmunotherapy (RIT) relies on radioactivity to destroy cells distant from immunotargeted cells. Therefore, even heterogeneous tumors (for antigen recognition) can be treated, because not all cells have to be targeted.
openaire   +2 more sources

Clinical practice recommendations for the use of next-generation sequencing in patients with solid cancer: a joint report from KSMO and KSP [PDF]

Journal of Pathology and Translational Medicine
In recent years, next-generation sequencing (NGS)–based genetic testing has become crucial in cancer care. While its primary objective is to identify actionable genetic alterations to guide treatment decisions, its scope has broadened to encompass aiding
Miso Kim, Hyo Sup Shim, Sheehyun Kim, In Hee Lee, Jihun Kim, Shinkyo Yoon, Hyung-Don Kim, Inkeun Park, Jae Ho Jeong, Changhoon Yoo, Jaekyung Cheon, In-Ho Kim, Jieun Lee, Sook Hee Hong, Sehhoon Park, Hyun Ae Jung, Jin Won Kim, Han Jo Kim, Yongjun Cha, Sun Min Lim, Han Sang Kim, Choong-Kun Lee, Jee Hung Kim, Sang Hoon Chun, Jina Yun, So Yeon Park, Hye Seung Lee, Yong Mee Cho, Soo Jeong Nam, Kiyong Na, Sun Och Yoon, Ahwon Lee, Kee-Taek Jang, Hongseok Yun, Sungyoung Lee, Jee Hyun Kim, Wan-Seop Kim   +36 more
doaj   +1 more source

Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis

Frontiers in Immunology, 2023
IntroductionGut microbiota can significantly affect the effectiveness of immune checkpoint inhibitors (ICIs) in cancer patients. Recently, antibiotics were shown to decrease survival rate of patients treated by ICIs.
Sébastien Lopes, Lucile Pabst, Anne Dory, Marion Klotz, Bénédicte Gourieux, Bruno Michel, Céline Mascaux, Céline Mascaux   +7 more
doaj   +1 more source

Myelopoiesis during Solid Cancers and Strategies for Immunotherapy

Cells, 2021
Our understanding of the relationship between the immune system and cancers has undergone significant discovery recently. Immunotherapy with T cell therapies and checkpoint blockade has meaningfully changed the oncology landscape.
Tyler J. Wildes, Bayli DiVita Dean, Catherine T. Flores   +2 more
doaj   +1 more source